Skip to main content
. 2023 Apr 27;329(20):1792–1794. doi: 10.1001/jama.2023.5038

Figure 2. Active Buprenorphine Prescribers and Prescription Volume by DATA Waiver Patient Limit, May 2021.

Figure 2.

Active prescribers included any Drug Enforcement Administration Drug Addiction Treatment Act (DATA)–waivered clinician with 1 or more prescriptions of buprenorphine with an indication for opioid use disorder in May 2021. Figure generated from authors’ analysis of IQVIA Xponent data January 2017 to May 2021 and the DATA-waivered practitioner roster January 2017 to May 2021.